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Abstract
The results of the GEDA 2014/2015-EHIS study demonstrate that during the last 12 months, 3.7% of women and 
6.0% of men in Germany had coronary heart disease (CHD – defined as myocardial infarction, chronic consequences 
of myocardial infarction or angina pectoris). The 12-month prevalence of CHD in men and women under 45 years 
of age is well below 1.0%; however, the prevalence rises rapidly and disproportionately up to 16.0% among women 
and 24.1% among men aged 75 years and over. Women with a low level of education have a considerably higher 
prevalence of CHD (7.3%) compared to those with a high level of education (1.2%). Men show fewer education-
related differences (6.5% versus 5.2%). As the indicators analysed here were first deployed as part of the 2014/2015 
European Health Interview Survey (EHIS), no comparative data is available.
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Introduction
Coronary heart disease or ischemic heart disease (CHD) 
is a chronic disease of the heart in which atherosclero-
sis leads to progressive narrowing of the coronary arter-
ies. This results in reduced supply of blood to the heart 
muscle [1]. Angina pectoris (chest tightness) is a frequent 
symptom in an advanced stage and is characterised by 
sudden pain behind the sternum. Common complica-
tions of CHD include myocardial infarction (heart attack), 
heart failure and arrhythmia, all of which are associated 
with a high mortality rate and significant deterioration 
to health.
CHD is the leading cause of death in Germany and 
throughout the world [1, 2]; it also results in high costs 
to health care systems [3, 4]. The rate of new cases (inci-
dence rate) and the mortality of CHD have been falling 
continuously in Germany for several decades [1]. This is 
most likely due to improvements in health-related behav-
iour (people refraining from smoking, increasing their 
level of physical activity and eating a balanced diet), in 
cardiometabolic risk profiles (high blood pressure, blood 
sugar levels, lipid metabolism) [5] and in the care pro-
vided to people with acute myocardial infarction [6]. 
Changes to the mortality rate or the incidence rate also 
affect the frequency of coronary heart disease found in 
the population (the prevalence of CHD). In addition, 
changes to the structure of the population, such as an 
increased proportion of older people due to demographic 
change, can also cause a numerical increase in CHD [1]. 
Therefore, it is essential that the age and gender-specific 
prevalence be regularly assessed in order to promptly 
identify positive and negative trends in CHD in the 
population, and to determine the potential for preven-
tion and the population’s need for medical care.
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Two indicators have been introduced into European 
health monitoring that can be used to measure the fre-
quency of myocardial infarction and its chronic conse-
quences, as well as chronic CHD or angina pectoris, in 
EU countries over time [7]. These indicators were meas-
ured in Germany for the first time as part of the German 
Health Update (GEDA) 2014/2015 study, which was con-
ducted by the Robert Koch Institute within the frame-
work of the European Health Interview Survey (EHIS) 
2014/2015 [8]. More detailed information about health 
monitoring and health indicators in Europe can be found 
in a Focus article published in this issue [9].
Indicator
In order to collect data on numerous disorders and con-
ditions, the GEDA 2014/2015-EHIS study posed the ques-
tion ‘During the past 12 months, have you had any of 
the following diseases or conditions?’ This question was 
followed by a list of illnesses; this enabled information 
to be collected about ‘myocardial infarction (heart 
attack)’, ‘chronic consequences of myocardial infarction’ 
and ‘coronary heart disease or angina pectoris’ in the 
past 12 months. Participants were able to complete the 
GEDA 2014/2015-EHIS questionnaire on paper or online.
The two indicators from European health monitoring 
used in the analyses presented here were defined as 1) 
the presence of a myocardial infarction or chronic con-
sequences of a myocardial infarction in the last 12 
months, and 2) the presence of coronary heart disease/
angina pectoris in the last 12 months [7]. Since myocar-
dial infarction and chronic CHD/angina pectoris are ulti-
mately manifestations of the same disease of the coro-
nary arteries, and because there are major overlaps 
between the two health problems, the two EHIS indica-
tors are summarised in the following as CHD. Defining 
CHD as either myocardial infarction or other forms of 
coronary heart disease is established practice in inter-
national health reporting [1, 3, 10-12].
The following analyses are based on data from 22,639 
respondents aged 18 years and above after 1,377 respond-
ents (5.7% of the total sample) were excluded from the 
analyses because valid information covering their 
12-month prevalence of myocardial infarction or chronic
consequences of myocardial infarction and coronary
heart disease/angina pectoris was missing. All analyses
were carried out using a weighting factor that corrected
for deviations in the sample from the population struc-
ture (as of 31 December 2014) in terms of gender, age,
municipality type and level of education. The Interna-
tional Standard Classification of Education (ISCED) was
used to ensure that the data gathered from the partici-
pants on education was comparable [13]. A detailed
description of the methodology applied in GEDA 2014/15-
EHIS can be found in the article German Health Update –
new data for Germany and Europe [8], which is published
in this issue.
Results and discussion
Over the last 12 months, a total of 3.7% of women and 
6.0% of men suffered from coronary heart disease 
(CHD; defined as a myocardial infarction, chronic con-
sequences of myocardial infarction, or angina pectoris – 
see Table 1). The 12-month prevalence of coronary heart 
disease in people under 45 years is well below than 1%; 
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims:  to provide reliable informati-
on about the population’s 
health status, health-related 
behaviour and health care in 
Germany, with the possibility 
of a European comparison
Method:   questionnaires completed 
on paper or online
Population:   people aged 18 years and 
above with permanent resi-
dency in Germany
Sampling:   registry office sample; ran-
domly selected individuals 
from 301 communities in 
Germany were invited to par-
ticipate
Participants:   24,016 people (10,872 men; 
13,144 women)
Response rate:  26.9%
Study period:  November 2014 – July 2015
Data protection:  all participants were informed 
about the study’s aims and 
content and about data pro-
tection, and provided their 
informed consent
More information is available at 
www.geda-studie.de
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Women % (95%-CI)
Women total 3.7 (3.3-4.2)
Age
18 – 44 years 0.2 (0.1-0.4)
45 – 54 years 0.9 (0.6-1.5)
55 – 64 years 3.4 (2.5-4.6)
65 – 74 years 7.1 (5.6-8.8)





Total (women and men) 4.8 (4.5-5.2)
CI=Confidence interval
Men % (95%-CI)
Men total 6.0 (5.5-6.5)
Age
18 – 44 years 0.4 (0.2-0.7)
45 – 54 years 3.4 (2.5-4.6)
55 – 64 years 7.7 (6.2-9.4)
65 – 74 years 13.0 (11.2-15.0)





Total (women and men) 4.8 (4.5-5.2)
however, it increases disproportionately to 16.0% in 
women and 24.1% in men aged over 75. Women with a 
low level of education report considerably more often 
that they had CHD in the last 12 months (7.3%) com-
pared to women with a high level of education (1.2%). 
Men show fewer education-related differences (6.5% 
versus 5.2%).
The indicators described here stem from European 
health monitoring [1, 11, 12, 14]. The results for the aggre-
gated CHD indicator confirm the known correlation 
between CHD and increasing age, male gender and lower 
socioeconomic status among adults in Germany [1, 14]. 
A comparison to the rest of Europe demonstrates a very 
low level of variability in the 12-month prevalence of myo-
cardial infarction and its chronic consequences or cor-
onary heart disease between the EU member states [9].
A direct comparison of prevalences for the new EHIS 
indicators with other epidemiological data is only pos-
sible to a limited extent. There are a number of meth-
odological reasons for this. On the one hand, the EHIS 
study measured myocardial infarction together with 
chronic consequences of myocardial infarction. Con-
sequently, the EHIS study for the first time uses a mixed 
indicator that is more strongly influenced by the par-
ticipants’ subjective perceptions, which are also likely 
to be affected by their education, gender and other fac-
tors. On the other hand, the EHIS study did not ask 
directly whether an illness had been diagnosed by a 
physician; doing so is standard practice in international 
health surveys [11, 12, 14]. Therefore, it is highly likely 
that the participants’ subjective perceptions and pat-
terns of interpretation affected the level of prevalence 
identified by the EHIS study more strongly than is usu-
ally the case.   
In addition, epidemiological studies and health 
reporting [1, 11, 12, 14] normally study lifetime preva-
Table 1 
12-month prevalence of coronary heart
disease (myocardial infarction, chronic
consequences of myocardial infarction or 
chronic coronary heart disease/angina 
pectoris) by gender, age and educational 
status (n=22,639) 
Source: GEDA 2014/2015-EHIS
In the last 12 months, 3.7% 
of women and 6.0 % of men 
in Germany suffered from 
coronary heart disease  
(CHD – defined as myocardial 
infarction, chronic conse-
quences of myocardial  
infarction or angina pectoris).
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lence; in contrast, EHIS for the first time measured the 
12-month prevalence and applied it to comparisons
between the countries in Europe. The last studies that
estimated lifetime prevalence of CHD in Germany were
the GEDA studies 2009-2012: they estimated lifetime
prevalence to be 6.6% in women and 9.6% in men [1].
Moreover, there was no evidence of a change in prev-
alence over the preceding 12 years or of major differ-
ences with other countries [1, 14]. The fact that the prev-
alence among men and women described here is
considerably lower than the lifetime prevalence men-
tioned above can be explained by the short 12-month
reference period used in the EHIS study. In addition,
as the 12-month prevalence rates are significantly lower,
despite the inclusion of chronic consequences of myo-
cardial infarction, this could indicate that a high pro-
portion of people who survive a myocardial infarction
do not experience chronic secondary symptoms. As
pointed out above, however, the validity of the mixed
indicator is difficult to judge due to the inclusion of
perceived chronic consequences.
The questionnaire used in the EHIS study was devel-
oped through an extensive process of consultation 
undertaken between the 28 European countries [7-9]. 
With regard to the questions posed about chronic dis-
eases, the decision was taken to record perceived 
illnesses instead of the usual focus on physician-diag-
nosed diseases. Moreover, in the case of myocardial 
infarction and stroke, chronic consequences of the dis-
eases were also measured. This decision was taken 
because the results it would provide were viewed as of 
higher public health relevance than would have other-
wise been the case. This decision was also based on the 
assumption that results would be less strongly influ-
enced by regional care differences [7, 9, 15]. Furthermore, 
the 12-month prevalence was measured in order to 
demonstrate the current extent of the disease and to 
reduce recall bias in data collection [7, 9, 15]. The meth-
odological difficulties described above and the lack of 
comparability with other data sources suggest that it is 
unlikely that the EHIS indicators measuring myocardial 
infarction und coronary heart disease, as well as the indi-
cators for stroke (compare Fact sheet on stroke in this 
issue [15]), will be applied in other studies.
Despite these limitations, the new EHIS indicators 
are still of value for harmonised, indicator-supported 
health monitoring in the EU. Moreover, they can help to 
identify regional inequalities, positive and negative 
trends and the potential for disease prevention in Euro-
pean populations as well as to demonstrate the areas of 
public health in which action needs to be taken.
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